NCT03380026
- Conditions
- Cutaneous T-Cell Lymphoma, Cutaneous T-cell Lymphoma Stage I, Dermatitis, +21 more
- Locations
-
- Rochester Skin Lymphoma Medical Group, PLLC Fairport, New York, United States
Clinical trial condition
Cutaneous T-Cell Lymphoma
Explore clinical trials studying Cutaneous T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.
40 public trials
7 recruiting studies
Cutaneous T-Cell Lymphoma trial results
NCT00425555
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham/ Kirklin Clinic Kirklin Clinic Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- University of California at Los Angeles Dept. of Hematology-Oncology Los Angeles, California, United States
- Florida Academic Dermatology Center Miami, Florida, United States
NCT02676778
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Eisai Trial Site #1 Nagoya, Aichi-ken, Japan
- Eisai Trial Site #2 Nagoya, Aichi-ken, Japan
- Eisai Trial Site #1 Kashiwa, Chiba, Japan
- Eisai Trial Site #1 Ōta, Gunma, Japan
NCT02593045
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Stanford Cancer Center Stanford, California, United States
- Ohio State University Columbus, Ohio, United States
- Hôpital Saint-Louis Paris, France
- Leiden University Medical Center Leiden, Netherlands
NCT01578499
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Los Angeles, California, United States
- Palo Alto, California, United States
- Chicago, Illinois, United States
- Boston, Massachusetts, United States
NCT00744991
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stanford, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
NCT00554827
- Conditions
- Cutaneous T-Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Stanford University School of Medicine Redwood City, California, United States
- Yale University School of Medicine New Haven, Connecticut, United States
- Emory University Atlanta, Georgia, United States
Completed
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
NCT01134341
- Conditions
- Cutaneous T-Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT00106431
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- UCLA Jonsson Cancer Center Los Angeles, California, United States
- Stanford Comprehensive Cancer Center Stanford, California, United States
- Boston Medical Center Boston, Massachusetts, United States
- University of Pennsylvania Abrahamson Cancer Center Philadelphia, Pennsylvania, United States
NCT00038025
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Cutaneous T-Cell Lymphoma, +22 more
- Locations
-
- M. D. Anderson Cancer Center Houston, Texas, United States